LogicBio Therapeutics Inc
Change company Symbol lookup
Select an option...
LOGC LogicBio Therapeutics Inc
RCLFW Rosecliff Acquisition Equity I Warrants Exp 11 Feb 2026 *W EXP 02/11/2026
FAST Fastenal Co
UKOMW Ucommune International Equity Warrant Exp 17th Nov 2025 *W EXP 11/17/2025
KMI Kinder Morgan Inc
RSG Republic Services Inc
TGEN Tecogen Inc
EPAM Epam Systems Inc
ISLE Isleworth Healthcare Acquisition Corp
TRMD Torm PLC
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Blend
Company profile

LogicBio Therapeutics, Inc. is a clinical-stage genetic medicine company. It is focused on genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. Its genome editing platform, GeneRide, is an approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid repair process, potentially to durable therapeutic protein expression levels. Its gene delivery platform, sAAVy, is an adeno-associated virus (AAV) capsid engineering platform designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate, LB-001 is developed for the treatment of methylmalonic acidemia (MMA) in pediatric patients. LB-001 is designed to introduce a functional copy of the methylmalonyl-CoA mutase (MUT) gene into the genome of MMA patients. It is developing LB-401 for the treatment of hereditary tyrosinemia type 1. It is also developing LB-301 for the treatment of Crigler-Najjar syndrome (CN).

Price
Delayed
$0.4135
Day's Change
0.017 (4.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.4599
Day's Low
0.391
Volume
(Light)

Today's volume of 33,003 shares is on pace to be much lighter than LOGC's 10-day average volume of 200,440 shares.

33,003
  • Prev Close
    0.3965
  • Today's Open
    0.41
  • Day's Range
    0.391-0.4599
  • Avg Vol (10-day)
    200.4K
  • Last (time)
    1:02p ET 07/06/22
  • Last (size)
    100
  • 52-Wk Range
    0.3422 - 5.15
    LowHigh
  • (09/24/21 - 05/12/22)
    20.84%
  • 124.4%
  • Market Cap
    13.6M
  • Shares Outstanding
    33.0M
  • -1.12
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 47.68
  • (% of float 06/15/22)
    0.49

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.